Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Allergan and Inspire sign copromotion agreement for Elestat

Dec. 11, 2003

Clinical trials confirm the good safety profile of anecorvate acetate

Dec. 3, 2003

New calpain inhibitors, their preparation and use, reported by Senju team

Nov. 26, 2003

DES may facilitate repair of damaged nerve cells

Nov. 19, 2003

Two phase III studies for Retaane planned for January

Nov. 18, 2003

Inhibition of glutamate carboxypeptidase II as a novel approach to diabetic retinopathy

Nov. 14, 2003

Lexicon moves into ophthalmology

Nov. 11, 2003

NDA accepted for antiinflammatory-antibiotic combination product

Nov. 7, 2003

AL-2512 as a potentially safer ocular antiinflammatory agent

Oct. 21, 2003

Visudyne approved in Japan for wet AMD

Oct. 20, 2003

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...